Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis.
Journal of the American Society of Nephrology : JASN
washington; pmrc; spokane; Biopsy; Disease Progression; Fibrosis; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Kidney Diseases; Nephrosis, Lipoid; Nephrotic Syndrome; Prognosis; Sclerosis
BACKGROUND: Heterogeneity in disease course and treatment response among patients with MCD/FSGS necessitates a granular evaluation of kidney tissue features. This study aimed to identify histologic and ultrastructural descriptors of structural changes most predictive of clinical outcomes in the Nephrotic Syndrome Study Network (NEPTUNE).
METHODS: Forty-eight histologic (37 glomerular, 9 tubulointerstitial, 2 vascular) and 20 ultrastructural descriptors were quantified by applying the NEPTUNE Digital Pathology Scoring System to NEPTUNE kidney biopsies. Outcomes included time from biopsy to disease progression, first complete remission of proteinuria, and treatment response. Relative importance of pathology and clinical predictors was obtained from random forest models, and predictive discrimination was assessed.
RESULTS: Among 224 participants (34% Black, 24% Hispanic), model performance was excellent, with predictive discrimination of 0.9 for disease progression, 0.85 for complete remission, and 0.81 for treatment response. The most predictive descriptors of outcomes included both conventional-
CONCLUSIONS: The most predictive descriptors of clinical outcomes among MCD/FSGS patients reflected structural changes in multiple renal compartments. Reporting these descriptors should be standardized to guide prognostication of proteinuric glomerular diseases.
Kidney & Diabetes
Zee, Jarcy; Liu, Qian; Smith, Abigail R; Hodgin, Jeffrey B; Rosenberg, Avi; Gillespie, Brenda W; Holzman, Lawrence B; Barisoni, Laura; Mariani, Laura H; Nephrotic Syndrome Study Network (NEPTUNE); NEPTUNE Members; and Tuttle, Katherine, "Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis." (2022). Articles, Abstracts, and Reports. 7004.